Contact
DMCA
Privacy
Robuta
https://pubmed.ncbi.nlm.nih.gov/3498891/
A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma
A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma
a new
monoclonal antibody
tumor marker
defined
pancreatic
https://www.sigmaaldrich.com/US/en/tech-docs/paper/134001
cis-Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice. | Sigma-Aldrich
cis-Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice. by Dietrich Sturm, Claudia Maletzki, Dagmar Braun, Joerg Emmrich. International...
pancreatic carcinoma
growth inhibition
cis
hydroxyproline
mediated
https://www.news-medical.net/news/2008/04/16/37407.aspx
Two new clinical trials show promise for basal cell carcinoma and pancreatic cancer
Clinical researchers at Scottsdale Healthcare and TGen have announced the results of two clinical trials that show promise for patients battling cancer.
basal cell carcinoma
two new
clinical trials
show
promise